18/07/2017 - 06:53

Perth biotech turns out record revenue result

18/07/2017 - 06:53

Bookmark

Save articles for future reference.

Perth based medical research pioneer Epichem, a wholly owned subsidiary of ASX listed PharmAust, has posted record revenues for FY17 on the back of growth across all of its business divisions. PharmAust said Epichem generated a best-ever revenue result of $3.05m for the 12 months to June, up by 30 per cent when compared to the previous year.  

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options